Astex uses a fragment-based approach to discover and develop small molecule molecularly targeted drugs for the treatment of cancer and other human diseases with significant unmet medical need. More
The Deutsche Krebsforschungszentrum (DKFZ) Heidelberg was founded as a non-profit organization and supraregional research center by the Land (state) Baden-Württemberg in 1964. More
Karyon's research and development focuses on drug delivery; specifically discovery, identification, patenting and development of peptides that target specific cancer tissue More